Recent advances in small molecule gonadotrophin-releasing hormone receptor antagonists

Expert Opinion on Therapeutic Patents

Volumn 14, Issue 2, 2004, Pages 187-199

  Zhu, Yun Fei ^a   Chen, Chen ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Gonadotrophin releasing hormone (GnRH) receptor; Small molecule antagonist

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR; GUANIDINE DERIVATIVE; INDOLE DERIVATIVE; PEPTIDE HORMONE ANTAGONIST; PYRIMIDINONE DERIVATIVE; PYRROLOPYRIMIDINE DERIVATIVE; QUINOLINE DERIVATIVE; SUFUGOLIX; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BINDING AFFINITY; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; NONHUMAN; PATENT; RECEPTOR AFFINITY; REVIEW; SIDE EFFECT; SLEEP DISORDER; STRUCTURE ACTIVITY RELATION;

EID: 1242352550     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.14.2.187     Document Type: Review

References (24)

1. MATSUO H, BABA Y, NAIR RMG, ARIMURA A, SCHALLY AV: Structure of the porcine LH- and FSH-releasing hormone I. The proposed amino acid sequence. Biochem. Biophys. Res. Commun. (1971) 43:1334-1339.
2. FILICORI M: Gonadotrophin-releasing hormone agonists. A guide to use and selection. Drugs (1994) 48:41-58 [Erratum in Drugs (1994) 48:326].
3. EMONS G, SCHALLY AV: The use of luteinising hormone releasing hormone agonist and antagonists in gynaecological cancers. Hum. Reprod. (1994) 9:1364-1379.
4. CONN PM, CROWLEY WF: Gonadotrophin-releasing hormone and its analogues. N. Engl. J. Med. (1991) 324:93-103.
5. HERBST KL: Gonadotrophin-releasing hormone antagonists. Curr. Opin. Pharmacol. (2003) 3:660-666.
6. CHENGALVALA MV, PELLETIER JC, KOPF GS: GnRH agonists and antagonists in cancer therapy. Curr. Med. Chem. (2003) 3:399-410.
7. SASAKI S, CHO N, NARA Y et al.: Discovery of a thieno [2,3-d] pyrimidine-2.4-dione bearing a p-methoxyureidophenyl moiety at the position 6: a highly potent and orally bioavailable non-peptide antagonist for human luteinising hormone-releasing hormone receptor. J. Med. Chem. (2003) 46:113-124.
8. HARA T, ARAKI H, KUSAKA M et al.: Suppression of a pituitary-ovarian axis by chronic oral administration of a novel non-peptide gonadotriphin-releasing hormone antagonist, TAK-013, in cynomolgus monkeys. J. Clin. Endocrinol. Metab. (2003) 88:1697-1704.
9. CLARK E, BOYCE M, WARRINGTON S et al.: Effect of single dose of TAK-013, a new non-peptide orally active gonadotrophin-releasing hormone antagonist, in healthy young men. Proc. Br. Pharmacol. Soc. Clin. Pharmacol. Section, Br. J Clin. Pharmacol. (2003) 55:443.
10. SASAKI S, IMAEDA T, HAYASE Y et al.: A new class of potent non-peptide luteinising hormone-releasing hormone (LHRH) antagonists: design and synthesis of 2-phenylimidazo [1,2-a] pyrimidin-5-ones. Bioorg. Med. Chem. Lett. (2002) 12:2073-2077.
11. ASHTON WT, SISCO RM, YANG YT et al.: Potent non-peptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus. Bioorg. Med. Chem. Lett. (2001) 11:1727-1731.
12. YOUNG JR, HUANG SX, WALSH TF et al.: 2-Arylindoles as gonadotrophin releasing hormone (GnRH) antagonists: optimisation of the tryptamine side chain. Bioorg. Med. Chem. Lett. (2002) 12:827-832.
13. ASHTON WT, SISCO RM, KIECZYKOWSKI GR et al.: Orally bioavailable indole-based non-peptide GnRH receptor antagonists with high potency and functional activity. Bioorg. Med. Chem. Lett. (2001) 11:2597-2602.
14. ASHTON WT, SISCO RM, YANG YT et al.: Substituted indole-5-carboxamides and -acetamides as potent non-peptide GnRH receptor antagonists. Bioorg. Med. Chem. Lett. (2001) 11:1723-1726.
15. YOUNG JR, HUANG SX, CHEN I et al.: Quinolones as gonadotrophin-releasing hormone (GnRH) antagonists: simultaneous optimisation of the C(3)-aryl and C(6)-substituents. Bioorg. Med. Chem. Lett. (2000) 10:1723-1727.
16. 1H]-quinolone antagonist for the gonadotrophin-releasing hormone receptor. J. Med. Chem. (2001) 44:917-922.
17. ZHU YF, STRUTHERS RS, CONNORS PJ et al.: Initial structure-activity relationship studies of a novel series of pyrrolo [1,2-a] pyrimid-7-ones as GNRH receptor antagonists. Bioorg. Med. Chem. Lett. (2002) 12:399-402.
18. ZHU YF, GUO Z, GROSS TD et al.: Design and structure-activity relationships of 2-alkyl-3-aminomethyl-6-(3-methoxyphenyl)-7-methyl-8-(2-fluorobenzyl imidazolo [1,2-a)pyrimid-5ones as potent GnRH receptor antagonists. J. Med. Chem. (2003) 46:1769-1772.
19. ZHU YF, GROSS TD, GUO Z et al.: Identification of 1-arylmethyl-3-(2-aminoethyl)-5-aryluracil as novel gonadotrophin-releasing hormone receptor antagonists. J. Med. Chem. (2003) 46:2023-2026.
20. GUO Z, ZHU YF, TUCCI FC et al.: Synthesis and structure-activity relationships of 1-arylmethyl-3-(2-aminopropyl)-5-aryl-6-methyluracils as potent GnRH receptor antagonists. Bioorg. Med. Chem. Lett. (2003) 13:3311-3315.
21. LUTHIN DR, HONG Y, PATHAK VP et al.: The discovery of novel small molecule non-peptide gonadotrophin-releasing hormone (GnRH) receptor antagonists. Bioorg. Med. Chem. Lett. (2002) 12:3467-3470.
22. LUTHIN DR, HONG Y, TOMPKINS E et al.: Characterization of mono- and diaminopyrimidine derivatives as novel, non-peptide gonadotrophin-releasing hormone (GnRH) receptor antagonists. Bioorg. Med. Chem. Lett. (2002) 12:3635-3639.
23. ANDERES KL, LUTHIN DR, CASTILLO R et al.: Biological characterization of a novel, orally active small molecule gonadotrophin-releasing hormone (GnRH) antagonist using castrated and intact rats. J. Pharma. Exp. Therap. (2003) 305:688-695.
24. STRUTHERS RS, PAN H, YEN S et al.: Orally-active, non-peptide GnRH antagonists. The 7th International Symposium on GnRH Analogues in Cancer and Human Reproduction. Amsterdam, The Netherlands (5-8 February 2003).